Anzeige
Mehr »
Donnerstag, 12.06.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
41 Leser
Artikel bewerten:
(0)

Rising star MitoQ Ltd launches two new products to add to growing line-up of world class 'Nutraceuticals'


AUCKLAND, New Zealand, Dec. 1, 2016 /PRNewswire/ -- The New Zealand team behind the MitoQ range of innovative and effectual health supplements have launched two 'super nutraceuticals' designed to assist in aging with vitality.

Photo - http://photos.prnewswire.com/prnh/20161129/444001

The first new formulation sees MitoQ paired with Longvida® Curcumin, an optimised curcumin extract from turmeric for brain and digestive health. MitoQ and GLME (New Zealand Green Lipped Mussel Oil Extract) are combined to support respiratory and joint health in the second new combination.

MitoQ is the ground-breaking mitochondria-targeting antioxidant developed at the University of Otago. Mitochondrial dysfunction is associated with ageing, lower energy levels and more than 200 health conditions. MitoQ works by optimising the mitochondria, the 'cellular batteries' within our cells, where it works to improve function and support against free radical damage to the cells.

Considered a significant advance in antioxidant technology, MitoQ is the world's first mitochondria-targeted antioxidant proven to be hundreds of times more effective than regular CoQ10 or Ubiquinol.

MitoQ has recently been selected for study by the US National Institute on Aging, one of only 28 compounds selected for this elite programme. This will add to the 180 independent research papers that have been published on MitoQ, a number that continues to grow.

The current range of MitoQ health supplements includes the original MitoQ (5mg) plus complementary compounds which target specific organs; MitoQ Liver and MitoQ Heart as well as MitoQ Blood Sugar which aims to support blood sugar metabolism.

About MitoQ + GLME
The only product in the world to combine the power of 3rd generation CoQ10, MitoQ, with pure New Zealand Green Lipped Mussel Oil Extract (GLME). GLME is a highly-purified marine lipid extract, obtained by a special solvent-free process from New Zealand Green Lipped Mussels (Perna Canaliculus). This powerful natural extract contains a blend of dozens of natural oils, esters and sterols, unique to the Green Lipped Mussel, and not found in Fish Oil, it is also rich in Omega-3 fatty acids.

MitoQ + GLME

  • Supports normal healthy lung and airway function
  • Supports normal joint function and mobility
  • Supports prevention of wear and tear on joint tissue

About MITOQ + Curcumin

A double-action super supplement which supports normal immune response pathways and key organ health, including the brain and the digestive system.

MitoQ® + Curcumin is another world-first in that it combines the most advanced form of CoQ10, MitoQ, with Longvida® Optimized Curcumin. Curcumin is the most active constituent of Turmeric and is one of the most researched natural compounds available today. Longvida Optimized Curcumin Extract is a breakthrough turmeric ingredient that is highly potent, proven to be 65-100 times more bioavailable than standard curcumin.

MitoQ® + Curcumin

  • Supports brain health and function
  • Supports digestive system health
  • Supports improved energy and stamina
  • Supports healthy organ function, and long-term health and wellness

About MitoQ:

MitoQ nutraceuticals are now sold in more than 100 countries around the world, with demand increasing month on month. All MitoQ products are available online at mitoq.com.

MitoQ was developed by Prof. Rob Smith and Dr Mike Murphy at Otago University. It is owned by MitoQ Ltd, a subsidiary of Antipodean Pharmaceuticals Inc, based at Auckland's Viaduct Harbour.

There are currently seven MitoQ products distributed nationally and internationally; MitoQ Skin Serum

(RRP $149NZD), MitoQ 5mg (RRP $74.95NZD), MitoQ Blood Sugar, MitoQ Liver and MitoQ Heart (RRP $84.95NZD), MitoQ® + GLME and MitoQ® + Curcumin (RRP $99.95NZD).

Catriona Stewart
- CStewart@mitoq.com
- Phone: +64 9 379 822




© 2016 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.